Q-Centrix LLC Names New Chief Business Development Officer Jim Yamshak To Accelerate Growth Of Technology-Enabled Services Businesses

Veteran Healthcare Sales Executive Joins Q-Centrix Team in Implementing Plans to Meet the Growing Role of Quality in Improving Patient Outcomes

News provided by

Q-Centrix

Oct 27, 2014, 01:23 ET

CHICAGO, Oct. 27, 2014 /PRNewswire/ -- Q-Centrix, the leader in quality data abstraction and active surveillance technology-enabled services, named Jim Yamshak as its new chief business development officer. Yamshak brings more than two decades of experience building and leading sales organizations within the provider healthcare services and technology space. He will report to Q-Centrix CEO Milton Silva-Craig.

"Changes in federal regulation, reimbursement practices from payers, and macroeconomic factors are challenging hospitals to keep pace. To meet these challenges, we provide our partner hospitals with technology-enabled services that result in improved quality outcomes and reduced costs. Jim's wealth of experience in both healthcare services and healthcare technology make him an excellent choice to lead our business development efforts," explains Silva-Craig. "His expertise selling to large, multi-hospital systems will provide customer development insight as well as long-term strategic leadership as we expand our presence in the market."

Yamshak comes to Q-Centrix from radiology services solution provider, Foundation Radiology Group, Inc. He was instrumental in rapidly increasing revenues by 140% and significantly growing the client base as senior vice president of sales and marketing at Foundation. Prior to Foundation, Yamshak served as the senior vice president of sales for Emageon, Inc., a radiology technology solutions provider. While at Emageon, he was largely responsible for increasing sales that helped the company's annual revenues grow from $1.8 million in 2001, to $120 million in 2006. In addition, he played a significant role in restructuring the company's sales strategy and team in preparation for its sale to Amicas in April 2009. Previous to Emageon, Yamshak held an executive sales position at Alliance Imaging, Inc., a radiology equipment and services company. He was a key player in increasing the Alliance Imaging southern region's annual revenue from $11 million in 1992, to $49 million in 2001.

Yamshak holds a Bachelor of Science degree in business administration from Auburn University.

About Q-Centrix:
Q-Centrix aims to improve patient care in the U.S. through the use of market-leading technology coupled with the industry's largest and broadest team of nurse-educated, quality information specialists. Conducting in excess of a million quality data abstractions annually, Q-Centrix is a comprehensive quality partner to its hundreds of hospitals; providing active surveillance, abstraction, analysis and improvement services.

To learn more about the leader in clinical surveillance and quality data abstraction technology-enabled services, visit www.q-centrix.com.

About Sterling Partners:
Q-Centrix was welcomed into Sterling Partners' portfolio in December 2013. Sterling focuses on partnering with like-minded founders and entrepreneurs, and investing growth capital in small- and mid-market companies in industries with positive, long-term trends.

Contact: Cathy Felts, Director of Marketing, Q-Centrix
Office: 603.294.1145 ext. 131
Cell: 312.659.8243

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/q-centrix-llc-names-new-chief-business-development-officer-jim-yamshak-to-accelerate-growth-of-technology-enabled-services-businesses-839978773.html

SOURCE Q-Centrix